NumerixS Investment Technologies’s Regeneron Pharmaceuticals REGN Stock Holding History

NumerixS Investment Technologies’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,385	Closed	-$384K	–	1208
2019 Q3	$384K	Buy	+1,385	New	+$410K	0.1%	208
2019 Q2	–	Sell	-3,764	Closed	-$1.52M	–	1297
2019 Q1	$1.52M	Buy	+3,764	New	+$1.55M	0.2%	112
2018 Q4	–	Sell	-4,400	Closed	-$1.79M	–	1320
2018 Q3	$1.79M	Buy	4,400 +3,100	+238%	+$1.18M	0.34%	53
2018 Q2	$444K	Buy	+1,300	New	+$407K	0.1%	279
2017 Q3	–	Sell	-2,800	Closed	-$1.38M	–	1310
2017 Q2	$1.38M	Buy	+2,800	New	+$1.23M	0.2%	116
2016 Q3	–	Sell	-6,200	Closed	-$2.17M	–	1279
2016 Q2	$2.17M	Sell	6,200 -2,200	-26%	-$847K	0.3%	56
2016 Q1	$3.03M	Buy	8,400 +5,544	+194%	+$2.28M	0.35%	50
2015 Q4	$1.55M	Buy	+2,856	New	+$1.55M	0.19%	123
2015 Q1	–	Sell	-1,200	Closed	-$492K	–	672
2014 Q4	$492K	Buy	+1,200	New	+$472K	0.17%	181

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

NumerixS Investment Technologies's REGN Position: Q4 2019 in Review

NumerixS Investment Technologies sold out of Regeneron Pharmaceuticals (REGN) in Q4 2019, closing a stake of 1,385 shares — an estimated $384K sold.

NumerixS Investment Technologies first reported a position in REGN in Q4 2014 and held it in 9 quarters. The position peaked at $3.03M in Q1 2016. 702 funds tracked by Wall St. Rank hold REGN as of Q4 2019.

NumerixS Investment Technologies reported no remaining Regeneron Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
NumerixS Investment Technologies sold 1,385 Regeneron Pharmaceuticals shares in Q4 2019, an estimated $384K.
NumerixS Investment Technologies first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 9 quarters.
NumerixS Investment Technologies's Regeneron Pharmaceuticals position peaked at $3.03M in Q1 2016.
702 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2019.

Based on NumerixS Investment Technologies's 13F filing for Q4 2019, filed 12 Feb 2020.